“…Each TLR family member, with the exception of TLR3, signals through the MyD88-dependent pathway, initiated by the MyD88 adaptor protein, resulting in the activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) (a mediator of acute inflammation (Lawrence 2009)), mammalian target of rapamycin (mTOR) (central pathway, involved in regulation of multiple processes including inflammation (Galanopoulou 2013)) and generation of the pro-inflammatory cytokines, such as IL-6 and tumor necrosis factor alpha (TNF-α) (Takeda & Akira 2004, Wang, Lin & Yang 2011, Ravizza, Kostoula & Vezzani 2013). This evidence arose from surgically resected epileptic tissues of adult and pediatric patients with epilepsy showing the presence of inflammatory molecules in activated glial cells, neurons and endothelial cells of the blood-brain barrier (BBB) and indicating the strong link between inflammation and seizures (Crespel, Coubes, Rousset, Brana, Rougier, Rondouin et al 2002, Ravizza, Boer, Redeker, Spliet, van Rijen, Troost et al 2006, Aronica, Boer, van Vliet, Redeker, Baayen, Spliet et al 2007, Ravizza, Gagliardi, Noe, Boer, Aronica & Vezzani 2008, Maroso, Balosso, Ravizza, Liu, Aronica, Iyer et al 2010, Vezzani, French, Bartfai & Baram 2011, Zurolo, Iyer, Maroso, Carbonell, Anink, Ravizza et al 2011, Balosso, Ravizza, Aronica & Vezzani 2013, Iori, Maroso, Rizzi, Iyer, Vertemara, Carli et al 2013, Pernhorst, Herms, Hoffmann, Cichon, Schulz, Sander et al 2013).…”